CELL COUNTING WORKSHOP NIST
Transcript of CELL COUNTING WORKSHOP NIST
CELLCOUNTINGWORKSHOPNIST
PhilipMathuisApril10,2017
FROMIMAGETOACTION
2STRICTLYCONFIDENTIAL
ANALYZEIDENTIFYCOUNTVIABILITY
PATENTS
DIAGNOSTICSUPSIDE
PEOPLEANDECOSYSTEM
FUNDING
BEACHHEADMARKETBIOPROCESSING
BACKGROUND
16OVIZIO RESEARCHECOSYSTEM
GRANTSEQUITY
4.700K€15.211K€
SUSPENSIONUNITSADHERENTUNITS
6
OTHERPARTNERSAPPLIKONPALLLIFESCIENCES
FOUNDEDINDEC2009SPIN-OFFULBISO13485INPROGRESS
TOTALMARKET:3,46B$TOTAL#OFTESTS:200MCOSTPERSMEAR:18– 30$GROWTHRATE:4%
TOTALMARKET:1,1B$GROWTHRATE:6%
PAPSMEARSINUNITS
5.801
28.520
54
65
63
18 EUROPE
USA
ASIA
ROW
3
STRICTLYCONFIDENTIAL
7
1
ULBGRANTEDOVIZIOFILEDOVIZIOGRANTED
DDHM technology
4STRICTLYCONFIDENTIAL
PatentedviabilitymethodInventedbyprof.FrankDuboisULB(patentUS7,362,449&ep1631788)
INTENSITYIMAGE PHASEIMAGE
3DTOPVIEWIMAGE 3DIMAGE
REFOCUSSING
290CELLS– 95%CONF.
5
HOWDOWEANALYZEIMAGES
6STRICTLYCONFIDENTIAL
ACQUIREHOLOGRAM
COMPUTEPHASE
DETECTLIGHTCONES
REFOCUSALLOBJECTS
EXTRACTFINGERPRINT
HOLOGRAPHICFINGERPRINTFORCELLS
7STRICTLYCONFIDENTIAL
74PARAMETERSARERECORDEDPERCELL– MACHINELEARNING
VOLUME
DIAMETER
SIZE
CIRCULARITY
LENSBEHAVIOR
HEIGHTVARIANCE
MEMBRANEINTEGRITY
NUCLEUSTOCYTOPLASMRATIO
CELLPERIMETER
• IDENTIFY• DIFFERENTIATE• COUNT• COMPARE• ANALYZE• ASSESSVIABILITY
PARAMETERSSYSTEMMORPHOLOGYOPTICALPHASETEXTUREINTENSITYTEXTURE
MACHINELEARNINGMETHODOLOGY
8STRICTLYCONFIDENTIAL
STEP1LEARNINGSETCREATION
STEP2SYSTEMTRAINING
STEP3PREDICTION
100%LIVINGCELL
100%DEADCELLS
FEEDSYSTEMWITHKNOWNMIXTURES
FROM100%TO0%INSTEPSOF10
STEP1LEARNINGSETCREATION
STEP1LEARNINGSETCREATION
Proprietary&Confidential©2016Ovizio,AllRightsReserved 9
BENEFITS OF AUTOMATION
• INCREASEDCONTROL
• TIMEGAINANDTRACEABILITYOFRESULTS
• INCREASEDREPRODUCIBILITY
• DRASTICREDUCTIONOFMANUALOPERATIONS
• REDUCEDINVESTMENTANDFTECOST– FASTROI
OSONE:CELLVIABILITYINDICATORS
10STRICTLYCONFIDENTIAL
OSONE:SINGLECELLANALYSES
11STRICTLYCONFIDENTIAL
OSONE:WEBINTERFACE
12STRICTLYCONFIDENTIAL
CONTINUOUSMONITORING
13STRICTLYCONFIDENTIAL
STATISTICALRELEVANCEILINEF:6000IMAGESPERDAYCELLCOUNTER:50-100IMAGESPERSAMPLE
NODILLUTIONREQUIRED
Proprietary&Confidential©2016Ovizio,AllRightsReserved 14
OPC Integration
TECHNOLOGYCOMPARED
15STRICTLYCONFIDENTIAL
R=0,968
VARIABILITY-TCD
16STRICTLYCONFIDENTIAL
y=0.9771xR²=0.99007
02468
10121416
0 2 4 6 8 10 12 14 16
TCD-B
io-Con
nect2(1
0E+6cells/m
l)
TCD- BioConnect1(10E+6cells/ml)
TCD- COMPARISONy=1.0147xR²=0.98705
0
20
40
60
80
100
120
0 20 40 60 80 100 120Viab
ility-Bio-Co
nnect2
(%)
Viability- BioConnect1(%)
VIABILITYCOMPARISON
y=0.9933xR²=0.99651
0
2
4
6
8
10
12
14
0 2 4 6 8 10 12 14
VCD-B
io-Con
nect(1
0E+6cells/m
l)
VCD- BioConnect1(10E+6cells/ml)
VCDCOMPARISON INSAMPLE
CASESTUDY:VIRALLOADMEASUREMENT
17STRICTLYCONFIDENTIAL
PROTEINEXPRESSION
INFECTEDCELL
NON-INFECTEDCELL
Proprietary&Confidential©2016Ovizio,AllRightsReserved 18
CASESTUDY – DISCRIMINATECELLTYPES
• USCUSTOMER• IMMUNOTHERAPY• ENHANCED
DENDRITICCELLS• 6– DAYPROCESS
BACKGROUND
• IN-PROCESSCOUNTINGOFVIABLECELLDENSITYOF:• REDBLOODCELLS• GRANULOCYTES• LYMPHOCYTES• DENDRITICCELLS
• NOLOSSOFSAMPLEVOLUME
CHALLENGES
CRITICALPARAMETERSHEREARETOMONITORCELLCHARACTERISTICS
CELLTHERAPYCLOSEDMANUFACTURINGSYSTEMDENDRIDICCELLS
19Proprietary&Confidential©2016Ovizio,AllRightsReserved
MONOCYTES MDC’s LYMPHOCYTES GRANULOCYTES RBC’S
Proprietary&Confidential©2016Ovizio,AllRightsReserved 20
CASESTUDY– RESULTSCOUNT
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
OVIZIO FCM
6,5MCells/ml
Monocytes Lymphocytes Granulocytes
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
OVIZIO FCM
0,79MCells/ml
Monocytes Lymphocytes Granulocytes
MULTILAYERRECIPIENTS
21STRICTLYCONFIDENTIAL
MSCCELLS– XP10
MULTIPLATEOBSERVATION
XP10_Day5_plate1 XP10_Day5_plate3 XP10_Day5_plate6 XP10_Day5_plate8
Plate1 Plate3 Plate6 Plate8
22STRICTLYCONFIDENTIAL
CLIENTTEST:AUTOMATEDCONFLUENCY
23
20130205ClientMSC StemCells –70%
STRICTLYCONFIDENTIAL
CLIENTTEST:AUTOMATEDCONFLUENCY
24
20130205ClientMSC StemCells –90%
STRICTLYCONFIDENTIAL
OVIZIOVS MANUALMEASUREMENT
25
CONFLUENCEMEASUREMENTSMATCHTHEESTIMATIONSOFAHUMANOPERATORCLOSELY.CONFLUENCEISTHEPARAMETEROFMAINIMPORTANCEATTHISSTAGE.
STRICTLYCONFIDENTIAL
y=0.8417x+9.9266R²=0.89186
50
55
60
65
70
75
80
85
90
95
100
50 60 70 80 90 100
othercaptures
E116-MADCS2-1-J4
manualmeasurementoftheconfluence (%)
confluence
inOsO
ne(%)
Proprietary&Confidential©2016Ovizio,AllRightsReserved 26
THANKYOUFORYOURATTENTION!Wewouldlovetocontinuethediscussionwithyou…
IFYOUWANTTOTRYOURSYSTEMSSENDMAILTO:[email protected]